Where both FIT values were below 10 μg Hb per g, the prevalence of colorectal cancer was 0.17 per cent, indicating that 606 patients with 2 negative tests would need to be investigated to find 1 additional colorectal cancer. This evidence concerns the gene GSTM1 and colorectal cancer.